Table 2. Descriptive and clinical characteristics of the examined individuals (all), the study population (Aa-cultivation positive), and the reference group (Aa-negative) at baseline (BL), and at the two-year follow-up (FU) examination.
Examined individuals | ||||
Clinical | BL n = 500 | FU n = 397 | ||
n | % | n | % | |
N individuals (%) with sites AL ≥3 mm | 107 | 21.4 | 156 | 39.2 |
mean | SD | mean | SD | |
N of teeth (mean) with AL ≥3 mm | 0.52 | 1.37 | 1.92 | 3.34 |
Aa -cultivation-positive | ||||
BL n = 200 | FU n = 148 | |||
n | % | n | % | |
N individuals (%) with sites AL ≥3 mm | 54 | 27.0 | 82 | 54.4 |
mean | SD | mean | SD | |
N of teeth (mean) with AL ≥3 mm | 0.67 | 1.44 | 3.01 | 3.90 |
Reference group ( Aa -negative) | ||||
BL n = 228 | FU n = 190 | |||
n | % | n | % | |
N individuals (%) with sites AL ≥3 mm | 33 | 14.4 | 37 | 19.4 |
mean | SD | mean | SD | |
N of teeth (mean) with AL ≥3 mm | 0.34 | 1.28 | 0.89 | 2.63 |
AL; attachment loss; BL, at baseline; FU, at two-year follow-up.
Aa; Aggregatibacter actinomycetemcomitans.
SD; standard deviation.